InnovAge (INNV) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

INNV Stock Forecast

InnovAge stock forecast is as follows: an average price target of $6.80 (represents a 44.68% upside from INNV’s last price of $4.70) and a rating consensus of 'Hold', based on 4 wall street analysts offering a 1-year stock forecast.

INNV Price Target

The average price target for InnovAge (INNV) is $6.80 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $5.00. This represents a potential 44.68% upside from INNV's last price of $4.70.

INNV Analyst Ratings

Hold

According to 4 Wall Street analysts, InnovAge's rating consensus is 'Hold'. The analyst rating breakdown for INNV stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 4 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

InnovAge Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Feb 08, 2023	-	J.P. Morgan	$8.00	$7.50	6.67%	70.21%
Nov 23, 2022	-	Goldman Sachs	$8.00	$6.80	17.65%	70.21%
Nov 16, 2022	-	Citigroup	$8.00	$7.25	10.34%	70.21%
Sep 15, 2022	-	Barclays	$5.00	$4.94	1.21%	6.38%
Apr 20, 2022	-	Piper Sandler	$5.00	$6.59	-24.13%	6.38%

Row per page

Go to

The latest InnovAge stock forecast, released on Feb 08, 2023 by J.P. Morgan company, set a price target of $8.00, which represents a 6.67% increase from the stock price at the time of the forecast ($7.50), and a 70.21% increase from INNV last price ($4.70).

InnovAge Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$4.70	$4.70	$4.70
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of InnovAge stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to InnovAge's last price of $4.70. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 10, 2024	KeyBanc	-	Sector Weight	Initialise
Nov 23, 2022	Goldman Sachs	Neutral	Neutral	Hold
Nov 16, 2022	Citigroup	Neutral	Neutral	Hold
Dec 28, 2021	Goldman Sachs	-	Neutral	Downgrade
Dec 27, 2021	Barclays	-	Equal-Weight	Downgrade

Row per page

Go to

InnovAge's last stock rating was published by KeyBanc on Oct 10, 2024. The company Initialise its INNV rating from "null" to "Sector Weight".

InnovAge Financial Forecast

InnovAge Revenue Forecast

	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	$188.90M	$182.49M	$176.87M	$172.54M	$167.46M	$171.22M	$172.86M	$177.36M	$175.35M	$173.07M	$171.62M	$156.31M
Avg Forecast	$239.20M	$232.90M	$228.80M	$227.29M	$219.02M	$214.14M	$209.73M	$203.33M	$191.43M	$188.16M	$183.92M	$177.89M	$175.77M	$174.14M	$169.75M	$171.61M	$173.77M	$170.11M	$174.18M	$170.89M	$164.02M	$157.21M
High Forecast	$240.93M	$234.58M	$230.45M	$228.94M	$220.60M	$215.57M	$210.54M	$204.80M	$191.43M	$188.16M	$186.44M	$180.01M	$177.04M	$175.40M	$170.97M	$171.61M	$173.77M	$170.11M	$174.18M	$170.89M	$164.02M	$157.21M
Low Forecast	$238.02M	$231.75M	$227.67M	$226.17M	$217.94M	$213.16M	$208.72M	$202.32M	$191.43M	$188.16M	$181.39M	$176.70M	$174.90M	$173.28M	$168.91M	$171.61M	$173.77M	$170.11M	$174.18M	$170.89M	$164.02M	$157.21M
# Analysts	1	1	1	1	1	3	3	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	1.03%	1.03%	1.01%	0.99%	0.99%	1.00%	0.99%	1.04%	1.01%	1.01%	1.05%	0.99%

InnovAge's average Quarter revenue forecast for Mar 24 based on 1 analysts is $188.16M, with a low forecast of $188.16M, and a high forecast of $188.16M. INNV's average Quarter revenue forecast represents a -0.39% decrease compared to the company's last Quarter revenue of $188.90M (Dec 23).

InnovAge EBITDA Forecast

	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	3	3	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	$50.03M	$44.51M	$42.43M	$-4.28M	$-9.57M	$-13.13M	$-8.80M	$-2.71M	$4.92M	$14.52M	$13.84M	$-6.59M
Avg Forecast	$3.42M	$3.33M	$3.27M	$3.25M	$3.13M	$3.06M	$3.00M	$2.91M	$2.74M	$2.69M	$2.63M	$2.54M	$2.51M	$2.49M	$2.43M	$3.00M	$3.04M	$-6.42M	$3.05M	$2.99M	$2.87M	$-7.25M
High Forecast	$3.44M	$3.35M	$3.29M	$3.27M	$3.15M	$3.08M	$3.01M	$2.93M	$2.74M	$2.69M	$2.66M	$2.57M	$2.53M	$2.51M	$2.44M	$3.00M	$3.04M	$-5.14M	$3.05M	$2.99M	$2.87M	$-5.80M
Low Forecast	$3.40M	$3.31M	$3.25M	$3.23M	$3.11M	$3.05M	$2.98M	$2.89M	$2.74M	$2.69M	$2.59M	$2.53M	$2.50M	$2.48M	$2.41M	$3.00M	$3.04M	$-7.70M	$3.05M	$2.99M	$2.87M	$-8.69M
Surprise %	-	-	-	-	-	-	-	-	-	-	19.03%	17.51%	16.89%	-1.72%	-3.95%	-4.37%	-2.90%	0.42%	1.62%	4.86%	4.82%	0.91%

1 analysts predict INNV's average Quarter EBITDA for Mar 24 to be $2.69M, with a high of $2.69M and a low of $2.69M. This is -94.62% lower than InnovAge's previous annual EBITDA (Dec 23) of $50.03M.

InnovAge Net Income Forecast

	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	3	3	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	$-3.45M	$-10.30M	$-11.18M	$-7.31M	$-10.55M	$-13.70M	$-13.53M	$-3.16M	$1.11M	$7.69M	$6.47M	$-10.51M
Avg Forecast	-	-	-	-	$678.85K	$-1.36M	$-339.42K	$-5.09M	$-2.76M	$-4.75M	$-3.52M	$-5.00M	$-4.79M	$-6.43M	$-11.22M	$-4.02M	$-2.24M	$-7.62M	$6.55M	$6.83M	$8.84M	$-11.56M
High Forecast	-	-	-	-	$685.23K	$1.36M	$-337.24K	$-5.06M	$-2.75M	$-4.72M	$-2.82M	$-2.50M	$-4.76M	$-6.39M	$-11.15M	$-4.02M	$-2.24M	$-6.09M	$6.55M	$6.83M	$8.84M	$-9.25M
Low Forecast	-	-	-	-	$674.48K	$-2.72M	$-342.61K	$-5.14M	$-2.79M	$-4.79M	$-4.21M	$-6.25M	$-4.83M	$-6.49M	$-11.32M	$-4.02M	$-2.24M	$-9.14M	$6.55M	$6.83M	$8.84M	$-13.87M
Surprise %	-	-	-	-	-	-	-	-	-	-	0.98%	2.06%	2.33%	1.14%	0.94%	3.41%	6.03%	0.41%	0.17%	1.12%	0.73%	0.91%

InnovAge's average Quarter net income forecast for Mar 22 is $-7.62M, with a range of $-9.14M to $-6.09M. INNV's average Quarter net income forecast represents a -788.67% decrease compared to the company's last Quarter net income of $1.11M (Dec 21).

InnovAge SG&A Forecast

	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	3	3	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	$31.11M	$34.33M	$35.12M	$32.96M	$32.59M	$34.59M	$32.49M	$30.83M	$35.16M	$27.38M	$34.33M	$24.19M
Avg Forecast	$44.69M	$43.51M	$42.74M	$42.46M	$40.92M	$40.01M	$39.18M	$37.99M	$35.76M	$35.15M	$34.36M	$33.23M	$32.84M	$32.53M	$31.71M	$32.06M	$32.46M	$83.23M	$32.54M	$31.93M	$30.64M	$26.61M
High Forecast	$45.01M	$43.82M	$43.05M	$42.77M	$41.21M	$40.27M	$39.33M	$38.26M	$35.76M	$35.15M	$34.83M	$33.63M	$33.08M	$32.77M	$31.94M	$32.06M	$32.46M	$99.88M	$32.54M	$31.93M	$30.64M	$31.93M
Low Forecast	$44.47M	$43.30M	$42.53M	$42.25M	$40.72M	$39.82M	$38.99M	$37.80M	$35.76M	$35.15M	$33.89M	$33.01M	$32.68M	$32.37M	$31.56M	$32.06M	$32.46M	$66.58M	$32.54M	$31.93M	$30.64M	$21.28M
Surprise %	-	-	-	-	-	-	-	-	-	-	0.91%	1.03%	1.07%	1.01%	1.03%	1.08%	1.00%	0.37%	1.08%	0.86%	1.12%	0.91%

InnovAge's average Quarter SG&A projection for Mar 24 is $35.15M, based on 1 Wall Street analysts, with a range of $35.15M to $35.15M. The forecast indicates a 13.00% rise compared to INNV last annual SG&A of $31.11M (Dec 23).

InnovAge EPS Forecast

	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	3	3	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	$-0.03	$-0.08	$-0.08	$-0.05	$-0.08	$-0.10	$-0.10	$-0.02	$0.01	$0.06	$0.05	$-0.09
Avg Forecast	-	-	-	-	$0.01	$-0.01	$-0.00	$-0.04	$-0.02	$-0.03	$-0.03	$-0.04	$-0.04	$-0.05	$-0.08	$-0.03	$-0.02	$-0.00	$0.05	$0.05	$0.06	$-0.10
High Forecast	-	-	-	-	$0.01	$0.01	$-0.00	$-0.04	$-0.02	$-0.03	$-0.02	$-0.02	$-0.04	$-0.05	$-0.08	$-0.03	$-0.02	$-0.00	$0.05	$0.05	$0.06	$-0.10
Low Forecast	-	-	-	-	-	$-0.02	$-0.00	$-0.04	$-0.02	$-0.04	$-0.03	$-0.05	$-0.04	$-0.05	$-0.08	$-0.03	$-0.02	$-0.00	$0.05	$0.05	$0.06	$-0.10
Surprise %	-	-	-	-	-	-	-	-	-	-	0.98%	2.06%	2.34%	1.14%	0.94%	3.38%	6.07%	30.82%	0.17%	1.19%	0.77%	0.93%

According to 1 Wall Street analysts, InnovAge's projected average Quarter EPS for Mar 22 is $-0.00, with a low estimate of $-0.00 and a high estimate of $-0.00. This represents a -109.22% decrease compared to INNV previous annual EPS of $0.01 (Dec 21).

InnovAge Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
MODV	ModivCare	$16.31	$24.50	50.21%	Buy
INNV	InnovAge	$4.70	$6.80	44.68%	Hold
EHAB	Enhabit	$7.46	$10.25	37.40%	Hold
PNTG	Pennant Group	$30.78	$34.67	12.64%	Buy
SEM	Select Medical	$38.09	$40.00	5.01%	Buy
ENSG	Ensign Group	$144.66	$148.20	2.45%	Buy
EHC	Encompass Health	$98.93	$97.00	-1.95%	Buy

INNV Forecast FAQ

Is InnovAge a good buy?

No, according to 4 Wall Street analysts, InnovAge (INNV) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of INNV's total ratings.

What is INNV's price target?

InnovAge (INNV) average price target is $6.8 with a range of $5 to $8, implying a 44.68% from its last price of $4.7. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will InnovAge stock go up soon?

According to Wall Street analysts' prediction for INNV stock, the company can go up by 44.68% (from the last price of $4.7 to the average price target of $6.8), up by 70.21% based on the highest stock price target, and up by 6.38% based on the lowest stock price target.

Can InnovAge stock reach $7?

INNV's highest twelve months analyst stock price target of $8 supports the claim that InnovAge can reach $7 in the near future.

What are InnovAge's analysts' financial forecasts?

InnovAge's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $846.23M (high $851.5M, low $842.15M), average EBITDA is $12.1M (high $12.17M, low $12.04M), average net income is $-6.11M (high $-3.353M, low $-7.523M), average SG&A $158.09M (high $159.08M, low $157.33M), and average EPS is $-0.045 (high $-0.0247, low $-0.0554). INNV's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $928.19M (high $934.9M, low $923.6M), average EBITDA is $13.27M (high $13.36M, low $13.2M), average net income is $0 (high $0, low $0), average SG&A $173.41M (high $174.66M, low $172.55M), and average EPS is $0 (high $0, low $0).

Did the INNV's actual financial results beat the analysts' financial forecasts?

Based on InnovAge's last annual report (Jun 2023), the company's revenue was $688.09M, which missed the average analysts forecast of $691.27M by -0.46%. Apple's EBITDA was $162.84M, beating the average prediction of $10.43M by 1461.25%. The company's net income was $-40.673M, beating the average estimation of $-26.454M by 53.75%. Apple's SG&A was $135.26M, beating the average forecast of $129.14M by 4.74%. Lastly, the company's EPS was $-0.3, beating the average prediction of $-0.195 by 54.01%. In terms of the last quarterly report (Dec 2023), InnovAge's revenue was $188.9M, beating the average analysts' forecast of $183.92M by 2.71%. The company's EBITDA was $50.03M, beating the average prediction of $2.63M by 1803.30%. InnovAge's net income was $-3.447M, missing the average estimation of $-3.517M by -1.98%. The company's SG&A was $31.11M, missing the average forecast of $34.36M by -9.46%. Lastly, the company's EPS was $-0.0254, missing the average prediction of $-0.0259 by -1.94%